DARATUMUMAB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 23 adverse event reports in the FDA FAERS database where DARATUMUMAB was used for Neoplasm malignant.
Most Reported Side Effects for DARATUMUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Plasma cell myeloma | 2,980 | 10.9% | 680 | 439 |
| Infusion related reaction | 2,557 | 9.3% | 241 | 629 |
| Off label use | 2,494 | 9.1% | 425 | 783 |
| Pneumonia | 1,450 | 5.3% | 336 | 1,018 |
| Neutropenia | 1,351 | 4.9% | 192 | 371 |
| Drug ineffective | 1,110 | 4.1% | 240 | 217 |
| Thrombocytopenia | 1,089 | 4.0% | 199 | 374 |
| Death | 1,088 | 4.0% | 1,088 | 200 |
| Pyrexia | 1,032 | 3.8% | 140 | 592 |
| Dyspnoea | 996 | 3.6% | 98 | 404 |
| Neuropathy peripheral | 955 | 3.5% | 45 | 116 |
| Anaemia | 925 | 3.4% | 171 | 380 |
| Diarrhoea | 916 | 3.3% | 130 | 414 |
| Fatigue | 796 | 2.9% | 73 | 207 |
| Intentional product use issue | 711 | 2.6% | 56 | 108 |
Other Indications for DARATUMUMAB
Plasma cell myeloma (19,119)
Product used for unknown indication (4,960)
Plasma cell myeloma refractory (789)
Primary amyloidosis (609)
Amyloidosis (417)
Plasma cell leukaemia (192)
Plasma cell myeloma recurrent (131)
Plasmablastic lymphoma (79)
Plasmacytoma (79)
Nephrotic syndrome (63)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)